AbbVie (ABBV) Asset Utilization Ratio (2013 - 2026)
AbbVie (ABBV) posted quarterly Asset Utilization Ratio of 0.46 for Q1 2026, up 9.87% year-over-year from 0.42 in Q1 2025, and up 1.74% quarter-over-quarter from 0.46 in Q4 2025.
AbbVie (ABBV) Asset Utilization Ratio (2013 - 2026) Analysis & Trends
AbbVie (ABBV) has reported Asset Utilization Ratio for 14 consecutive years, with 0.46 the latest figure, recorded in Q1 2026.
- In Q1 2026, Asset Utilization Ratio rose 9.87% year-over-year to 0.46; the TTM figure through Mar 2026 stood at 0.46 (up 9.87% YoY), while the FY2025 annual figure was 0.45, up 8.87% from the prior year.
- Asset Utilization Ratio improved to 0.46 in Q1 2026 per ABBV's latest filing, from 0.46 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.46 in Q1 2026 and bottomed at 0.38 in Q2 2024.
- Historically, Asset Utilization Ratio has averaged 0.41 across 5 years, with a median of 0.41 in 2022.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio rose 17.43% — and 2024, when it fell 8.88%.
- AbbVie's Asset Utilization Ratio stood at 0.41 in 2022, then fell by 3.26% to 0.4 in 2023, then increased by 0.86% to 0.4 in 2024, then climbed by 12.91% to 0.46 in 2025, then rose by 1.74% to 0.46 in 2026.
- Business Quant data shows ABBV's Asset Utilization Ratio at 0.46 in Q1 2026, 0.46 in Q4 2025, and 0.44 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.37 Bn | 632.61 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 469.99 Bn | 463.42 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 303.26 Bn | 295.57 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.45 Bn | 252.55 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 236.73 Bn | 222.74 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 182.06 Bn | 178.88 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 159.32 Bn | 147.62 Bn | 10.94 Bn | 0.31 |
| 9 | Gsk | 106.03 Bn | 101.87 Bn | 8.24 Bn | 0.64 |
| 10 | Sanofi | 55.06 Bn | 47.68 Bn | 10.79 Bn | 0.36 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.47 |
| Mar 31, 2026 | 0.46 |
| Dec 31, 2025 | 0.46 |
| Sep 30, 2025 | 0.44 |
| Jun 30, 2025 | 0.43 |
| Mar 31, 2025 | 0.42 |
| Dec 31, 2024 | 0.40 |
| Sep 30, 2024 | 0.39 |
| Jun 30, 2024 | 0.38 |
| Mar 31, 2024 | 0.38 |
| Dec 31, 2023 | 0.40 |
| Sep 30, 2023 | 0.41 |
| Jun 30, 2023 | 0.42 |
| Mar 31, 2023 | 0.42 |
| Dec 31, 2022 | 0.41 |
| Sep 30, 2022 | 0.41 |
| Jun 30, 2022 | 0.40 |
| Mar 31, 2022 | 0.39 |
| Dec 31, 2021 | 0.38 |
| Sep 30, 2021 | 0.37 |